Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quickcomparison

Dose Range GHRP-6 (Growth Hormone Releasing Peptide-6) 100–300 mcg GHRP-2 Frequency Multiple times daily Administration Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Moderate (1-2 weeks) Rapid (hours to days) Evidence Level Limited human trials Mo

This comparison does not assign a generated winner or score.

  • Dose Range
  • GHRP-6 (Growth Hormone Releasing Peptide-6)
  • 100–300 mcg
  • GHRP-2
  • Frequency
  • Multiple times daily
  • Administration
  • Subcutaneous injection
  • Cycle Length
  • 8-12 weeks
  • Onset Speed
  • Moderate (1-2 weeks)
  • Rapid (hours to days)
  • Evidence Level
  • Limited human trials
  • Moderate human trials (Phase 1-2)
  • Efficacy
More references

Related material

Comparison

Quickcomparison

Dose Range GHRP-2 100–300 mcg GHRP-6 (Growth Hormone Releasing Peptide-6) Frequency Multiple times daily Administration Subcutaneous injection Cycle Length 8-12 weeks Onset Speed …

View details →
Comparison

Quickcomparison

Dose Range Pralmorelin (GHRP-2) 100–300 mcg GHRP-6 (Growth Hormone Releasing Peptide-6) Frequency Once daily Multiple times daily Administration Subcutaneous injection Cycle Lengt…

View details →